Morbidity and Mortality of Non-pancreatectomy operations for pancreatic cancer: An ACS-NSQIP analysis

Adams, Alexandra; Reames, Bradley N.; Krell, Robert W.

doi:10.1016/j.amjsurg.2022.08.012

Search citation statements

Order By: Relevance

Paper Sections

Select...

Pancreatic Cancer Screening1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As has already been articulated, pancreatic cancer is known for its aggressive nature and high mortality rates [117]. It has also been shown to occur in more than one member of the same family but is not thought to be hereditary in origin.…”

Section: Pancreatic Cancer Screeningmentioning

confidence: 96%

Pancreatic Cancer Health Disparity: Pharmacologic Anthropology

Wall,

Fuller,

Morcos

et al. 2023

Cancers

View full text Add to dashboard Cite

Pancreatic cancer (PCa) remains a formidable global health challenge, with high mortality rates and limited treatment options. While advancements in pharmacology have led to improved outcomes for various cancers, PCa continues to exhibit significant health disparities, disproportionately affecting certain populations. This paper explores the intersection of pharmacology and anthropology in understanding the health disparities associated with PCa. By considering the socio-cultural, economic, and behavioral factors that influence the development, diagnosis, treatment, and outcomes of PCa, pharmacologic anthropology provides a comprehensive framework to address these disparities and improve patient care.

show abstract

Section: Pancreatic Cancer Screeningmentioning

confidence: 96%